Equities

Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)44.72
  • Today's Change8.16 / 22.32%
  • Shares traded5.00
  • 1 Year change+11.94%
  • Beta1.2049
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.

  • Revenue in USD (TTM)770.01m
  • Net income in USD-141.45m
  • Incorporated2008
  • Employees2.40k
  • Location
    Tandem Diabetes Care Inc12400 High Bluff DriveSAN DIEGO 92130United StatesUSA
  • Phone+1 (858) 366-6900
  • Fax+1 (302) 636-5454
  • Websitehttps://www.tandemdiabetes.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Alphatec Holdings Inc482.26m-186.64m1.88bn839.00--24.33--3.91-1.54-1.543.980.73050.72731.447.06574,805.80-28.15-30.97-36.25-39.4764.3266.02-38.70-46.221.99-5.400.8345--37.4539.38-23.36--67.92--
UFP Technologies Inc407.33m47.88m2.01bn3.09k42.236.8233.794.946.216.2152.8238.461.024.506.71131,693.2011.999.6913.8010.9527.8926.3311.7510.141.4617.870.10330.0013.0816.007.5025.7114.08--
Conmed Corp1.26bn82.35m2.21bn4.00k27.48--14.321.752.612.6139.97--------315,387.00--0.8972--1.0254.9454.956.531.65--3.76--139.1619.067.68179.9910.042.890.00
STAAR Surgical Co322.42m21.35m2.24bn1.06k105.265.7683.976.940.43240.43246.537.900.71062.354.10305,317.304.706.775.407.9078.3676.896.629.165.08--0.00050.0013.3721.07-46.1833.8551.95--
Helen of Troy Limited2.01bn168.59m2.30bn1.93k13.691.4010.441.157.057.0583.6568.940.69712.485.191,040,503.005.867.696.909.5347.3144.328.419.240.99365.270.289---3.265.0917.67-0.65486.79--
Patterson Companies, Inc.6.57bn193.86m2.30bn7.60k12.652.388.210.35012.032.0368.8610.782.235.6114.48864,047.906.580.370211.300.565521.3021.052.950.18110.724312.080.4462846.10-0.42983.442.1410.798.220.00
Inari Medical Inc520.66m-23.62m2.44bn1.30k--5.45--4.68-0.409-0.4098.957.710.89131.587.75400,506.90-4.04-0.5941-4.57-0.669687.6789.06-4.54-0.62952.19--0.00--28.73135.4094.41--52.46--
ICU Medical Inc2.26bn-29.66m2.44bn14.00k--1.1412.171.08-1.23-1.2393.5587.960.50802.1611.79161,366.10-0.66691.46-0.74911.6532.7534.11-1.312.231.060.64840.43450.00-0.915410.0460.08---1.45--
Premier Inc1.32bn167.33m2.46bn2.80k14.721.038.371.871.391.3910.9719.950.35714.573.06470,033.204.4210.395.6713.0067.1362.0412.3722.601.32516.340.243119.11-6.762.44-34.17-15.30-2.29--
Enovis Corp1.71bn-54.37m2.81bn6.55k--0.818917.221.65-0.9987-0.611731.3362.610.38881.596.11260,640.80-1.23-0.3569-1.37-0.4158.2148.19-3.15-1.061.161.020.1199--9.22-4.89-40.29--11.91--
Tandem Diabetes Care Inc770.01m-141.45m2.89bn2.40k--11.88--3.75-2.17-2.1711.823.760.81262.748.35320,837.10-14.93-10.08-18.48-12.2349.2851.77-18.37-11.593.01--0.5884---6.6832.39-135.33--76.81--
Envista Holdings Corp2.56bn-120.40m3.27bn12.80k--0.7889299.561.27-0.713-0.71314.7224.090.39043.896.29200,226.60-1.831.94-2.152.3456.3557.65-4.705.291.935.090.26670.00-0.1012-2.04-142.10---4.22--
Procept Biorobotics Corp156.33m-103.37m3.31bn626.00--12.41--21.15-2.12-2.123.205.180.46851.814.08249,722.00-30.98---34.68--53.47---66.12--7.44--0.1629--81.55---21.51------
Axonics Inc387.14m-15.95m3.43bn797.00--5.47--8.86-0.3134-0.31347.7612.290.56061.208.53485,744.00-2.31-12.67-2.52-13.7675.2570.04-4.12-29.688.04--0.00--33.86249.0689.80--23.65--
LivaNova PLC1.19bn-31.72m3.47bn2.90k--2.84206.152.93-0.5904-0.590421.8922.560.49852.576.11408,630.00-1.33-6.01-1.54-7.4267.8966.99-2.67-13.562.712.000.3383--12.890.8278120.34---1.64--
Integer Holdings Corp1.63bn98.09m3.73bn10.50k38.642.4418.732.282.882.8847.8645.520.54524.914.95155,494.603.283.283.533.5326.5426.946.016.402.013.740.43030.0016.035.6238.719.3321.71--
Data as of May 03 2024. Currency figures normalised to Tandem Diabetes Care Inc's reporting currency: US Dollar USD

Institutional shareholders

63.06%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20238.11m12.35%
The Vanguard Group, Inc.as of 31 Dec 20236.93m10.56%
Capital Research & Management Co. (World Investors)as of 31 Dec 20236.38m9.73%
Eminence Capital LPas of 31 Dec 20235.17m7.88%
ArrowMark Colorado Holdings LLCas of 31 Dec 20232.94m4.47%
Jennison Associates LLCas of 31 Mar 20242.56m3.90%
Janus Henderson Investors US LLCas of 31 Dec 20232.55m3.88%
Fidelity Management & Research Co. LLCas of 31 Dec 20232.49m3.80%
SSgA Funds Management, Inc.as of 31 Dec 20232.27m3.47%
Bellevue Asset Management AGas of 31 Dec 20231.99m3.04%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.